Literature DB >> 1347744

A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.

A Baniahmad1, A C Köhne, R Renkawitz.   

Abstract

Inhibition of gene transcription is brought about by several mechanisms. The least understood mechanism is probably silencing, the analogue to transcriptional enhancing. We provide evidence that the silencing function of the oncogene product v-ERBA or the cellular counterpart, the thyroid hormone receptor (TR, c-erbA) is located in the C-terminal part and is transferable to a heterologous DNA binding domain. Deletion analyses suggest an important role for a basic and hydrophilic amino acid stretch on both ends of the domain. In addition we show that the related retinoic acid receptor (RAR) also contains a functional silencing domain similar in size and amino acid sequence. However, the activity of this domain can be neutralized by an additional domain in the C-terminus which functions cell specifically.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347744      PMCID: PMC556542          DOI: 10.1002/j.1460-2075.1992.tb05140.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  c-erbA encodes multiple proteins in chicken erythroid cells.

Authors:  J Bigler; R N Eisenman
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogene.

Authors:  M L Privalsky; P Boucher; A Koning; C Judelson
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

3.  The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements.

Authors:  C K Glass; J M Holloway; O V Devary; M G Rosenfeld
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

4.  Mutations that alter both localization and production of a yeast nuclear protein.

Authors:  P A Silver; A Chiang; I Sadler
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

5.  v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene.

Authors:  M Zenke; P Kahn; C Disela; B Vennström; A Leutz; K Keegan; M J Hayman; H R Choi; N Yew; J D Engel
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

Review 6.  Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation.

Authors:  T Graf; H Beug
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

7.  Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system.

Authors:  C C Thompson; C Weinberger; R Lebo; R M Evans
Journal:  Science       Date:  1987-09-25       Impact factor: 47.728

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

Review 9.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

10.  A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes.

Authors:  K Damm; H Beug; T Graf; B Vennström
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  93 in total

1.  Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex.

Authors:  Z Yang; S H Hong; M L Privalsky
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

2.  Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.

Authors:  U Dressel; D Thormeyer; B Altincicek; A Paululat; M Eggert; S Schneider; S P Tenbaum; R Renkawitz; A Baniahmad
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.

Authors:  D Li; F Wang; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Steroid receptor induction of gene transcription: a two-step model.

Authors:  G Jenster; T E Spencer; M M Burcin; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression.

Authors:  G Achatz; B Hölzl; R Speckmayer; C Hauser; F Sandhofer; B Paulweber
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

6.  Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates.

Authors:  Zheng Chen; James L Manley
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.

Authors:  Luciano De Haro; Ralf Janknecht
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

8.  Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding.

Authors:  G F Allan; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.

Authors:  C W Wong; M L Privalsky
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.

Authors:  B Martin; R Renkawitz; M Muller
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.